Positive: Purple Biotech reports positive results in Phase 2 CM24 pancreatic cancer study with potential new therapy.
From GlobeNewswire: 2024-08-16 08:12:00 Purple Biotech presented positive interim data from a Phase 2 CM24 pancreatic cancer study at ASCO
